|
"zhu j"的相關文件
顯示項目 96-104 / 104 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2012 |
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians
|
Li, H.; Kilpelaeinen, T. O.; Liu, C.; Zhu, J.; Liu, Y.; Hu, C.; Yang, Z.; Zhang, W.; Bao, W.; Cha, S.; Wu, Y.; Yang, T.; Sekine, A.; Choi, B. Y.; Yajnik, C. S.; Zhou, D.; Takeuchi, F.; Yamamoto, K.; Chan, J. C.; Mani, K. R.; Been, L. F.; Imamura, M.; Nakashima, E.; Lee, N.; Fujisawa, T.; Karasawa, S.; Wen, W.; Joglekar, C. V.; Lu, W.; Chang, Y.; Xiang, Y.; Gao, Y.; Liu, S.; Song, Y.; Kwak, S. H.; Shin, H. D.; Park, K. S.; Fall, C. H. D.; Kim, J. Y.; Sham, P. C.; Lam, K. S. L.; Zheng, W.; Shu, X.; Deng, H.; Ikegami, H.; Krishnaveni, G. V.; Sanghera, D. K.; Chuang, L.; Liu, L.; Hu, R.; Kim, Y.; Daimon, M.; Hotta, K.; Jia, W.; Kooner, J. S.; Chambers, J. C.; Chandak, G. R.; Ma, R. C.; Maeda, S.; Dorajoo, R.; Yokota, M.; Takayanagi, R.; Kato, N.; Lin, X.; Loos, R. J. F. |
| 國立臺灣大學 |
2009-05 |
Protein Array Identification of Substrates of the Epstein-Barr Virus Protein Kinase BGLF4.
|
Zhu, J; Liao, G; Shan, L; Zhang, J; Chen, MR; Hayward, GS; Hayward, SD; Desai, P; Zhu, H. |
| 國立臺灣大學 |
2008-01 |
Juvenile Hormone Connects Larval Nutrition with Target of Rapamycin Signaling in the Mosquito Aedes aegypti
|
Shiao, SH; Hansen, IA; Zhu, J; Sieglaff, DH; Raikhel, AS |
| 國立成功大學 |
2007-07-18 |
Sequential aquifer tests at a well field, Montalto Uffugo Scalo, Italy
|
Straface, S.; Yeh, Tian-Chyi Jim; Zhu, J.; Troisi, S.; Lee, C. H. |
| 國立成功大學 |
2007-05-01 |
Laboratory sandbox validation of transient hydraulic tomography
|
Liu, X.; Illman, W. A.; Craig, A. J.; Zhu, J.; Yeh, Tian-Chyi Jim |
| 國立臺灣大學 |
2007-02 |
Composite organic-inorganic nanoparticles as Raman labels for tissue analysis
|
Sun, L.; Sung, K.-B.; Dentinger, C.; Lutz, B.; Nguyen, L.; Zhang, J.; Qin, H.; Yamakawa, M.; Cao, M.; Lu, Y.; Chmura, A.J.; Zhu, J.; Su, X.; Berlin, A.A.; Chan, S.; Knudsen, B. |
| 國立成功大學 |
2006-10 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
Sollano, J.; De Man, R. A.; Mutimer, D.; Gish, R. G.; Chang, Ting-Tsung; Zhu, J.; Cross, A.; Brett-Smith, H. |
| 國立成功大學 |
2006-10 |
Entecavir (ETV) treatment through 96 weeks results in virologic and biochemical improvement in HBeAg(-) chronic hepatitis B patients (study ETV-027)
|
Akarca, U.; Hatzis, G.; Kitis, G.; Shouval, D.; Lai, C.; Cheinquer, H.; Chang, Ting-Tsung; Zink, R.; Zhu, J.; Brett-Smith, H. |
| 國立成功大學 |
2006-07 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
De Man, R. A.; Mutimer, D.; Gish, R.; Chang, Ting-Tsung; Zhu, J.; Cross, A.; Brett-Smith, H. |
顯示項目 96-104 / 104 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
|
